A precision diagnostics company focused on predictive biomarker development for improved patient care
Location: Israel, Haifa District, Binyamina
Employees: 11-50
Phone: +1 855-950-2112
Total raised: $43M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | ALIVE | alivevc.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.05.2022 | Series C | $35M | - |
| 21.01.2021 | Series B | $8M | - |
Mentions in press and media 19
| Date | Title | Description |
| 15.01.2024 | OncoHost: Guiding oncology treatment decisions with one blood draw | What OncoHost does OncoHost is a technology company headquartered in Binyamina, Israel, and Cary, North Carolina, transforming the approach to precision medicine for improved patient outcomes. OncoHost aims to understand the patient's uniq... |
| 13.05.2022 | OncoHost Raises $35 Million Series C Funding Round to Launch Blood Test That May Rewrite the Standard of Care for Precision Oncology | AI-Powered Precision Oncology Platform Enables Clinicians to Personalize Cancer Treatment Plans and Overcome Resistance Related Posts Data Intensity Expands Oracle Managed Service Provider Investment to Deliver Modernized Oracle E-Business ... |
| 11.05.2022 | A Y Combinator alum on how the startup hustle came at a steep cost—to her mental health | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The following essay was contributed by Trisha Bantigue, CEO and co-founder of the San Francisco-b... |
| 10.05.2022 | Israeli biotech startup OncoHost raises $35 million in funding to personalize cancer treatment using AI | Cancer is one of the leading causes of death in the United States. In 2017, every sixth death in the world is due to cancer, according to data from the Global Burden of Disease which estimates that 9.56 million people died prematurely as a ... |
| 10.05.2022 | $35 Million In New Funding For AI To Personalize Cancer Treatment | Israeli startup OncoHost announced today an upsized and oversubscribed $35 million Series C funding round, led by ALIVE Israel HealthTech VC, with the participation of Leumi Partners, Menora Mivtachim, OurCrowd and other existing investors. |
| 10.05.2022 | OncoHost Raises $35M for AI-Powered Precision Oncology Platform | What You Should Know: – OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israel... |
| 10.05.2022 | OncoHost Raises $35M in Series C Funding | OncoHost, a Binyamina, Israel-based precision oncology company focused on advancing improved personalized cancer therapy, raised $35M in Series C funding. The round was led by Alive Israel HealthTech VC, Leumi Partners, Menora Mivtachim, an... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 18.08.2021 | OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices | BINYAMINA, Israel, Aug. 18, 2021 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced it has been awarded this year's Best Practices Technology Innovation ... |
Show more